Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.3 USD | -0.43% | +2.14% | -4.77% |
03/05 | Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate | MT |
03/05 | J&J: to present advances in retinal diseases | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 359B | |
+26.08% | 662B | |
+21.85% | 546B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson : US FDA Flags Unsanitary Conditions At Emergent BioSolutions